Published in Circulation on February 01, 1992
Characterization of cloned aortic smooth muscle cells from young rats. Am J Pathol (1994) 1.29
Alterations in expression of myosin and myosin light chain kinases in response to vascular injury. Am J Physiol Cell Physiol (2000) 1.08
Vascular biology and invasive cardiology. The streams are beginning to merge. Circulation (1992) 1.06
Proliferative activity in peripheral and coronary atherosclerotic plaque among patients undergoing percutaneous revascularization. J Clin Invest (1993) 1.04
Percutaneous arterial gene transfer in a rabbit model. Efficiency in normal and balloon-dilated atherosclerotic arteries. J Clin Invest (1992) 0.99
Targeted expression of SV40 large T-antigen to visceral smooth muscle induces proliferation of contractile smooth muscle cells and results in megacolon. J Biol Chem (1999) 0.93
Antiproliferative and c-myc mRNA suppressive effect of tranilast on newborn human vascular smooth muscle cells in culture. Br J Pharmacol (1996) 0.84
The transition of smooth muscle cells from a contractile to a migratory, phagocytic phenotype: direct demonstration of phenotypic modulation. J Physiol (2016) 0.76
Novel Roles for Kv7 Channels in Shaping Histamine-Induced Contractions and Bradykinin-Dependent Relaxations in Pig Coronary Arteries. PLoS One (2016) 0.75
Nonmuscle myosin heavy chain-B expression in balloon-dilated and stented arteries: a study in the atherosclerotic Yucatan micropig. Neth Heart J (2005) 0.75
Are restenosis cells containing nonmuscle myosin really vascular smooth muscle cells? Circulation (1992) 0.75
Therapeutic approaches to the control of fibrocellular intimal hyperplasia after angioplasty. Br Heart J (1993) 0.75
Isolation of putative progenitor endothelial cells for angiogenesis. Science (1997) 30.27
Enhancer-dependent expression of human kappa immunoglobulin genes introduced into mouse pre-B lymphocytes by electroporation. Proc Natl Acad Sci U S A (1984) 17.51
Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res (1999) 11.32
Mosaic organization of DNA nucleotides. Phys Rev E Stat Phys Plasmas Fluids Relat Interdiscip Topics (1994) 10.43
Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med (1999) 10.16
Long-range correlations in nucleotide sequences. Nature (1992) 8.93
A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. N Engl J Med (1994) 7.96
VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J (1999) 6.62
Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci U S A (2000) 6.59
Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. J Clin Invest (1998) 5.95
A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators. N Engl J Med (1998) 4.68
Mouse model of angiogenesis. Am J Pathol (1998) 4.28
Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia. Circulation (2001) 4.17
Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia. Circulation (1998) 4.10
The morphogen Sonic hedgehog is an indirect angiogenic agent upregulating two families of angiogenic growth factors. Nat Med (2001) 3.85
Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization. Circ Res (1998) 3.79
Simvastatin strongly reduces levels of Alzheimer's disease beta -amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo. Proc Natl Acad Sci U S A (2001) 3.50
Age-dependent impairment of angiogenesis. Circulation (1999) 3.47
Increased coronary perforation in the new device era. Incidence, classification, management, and outcome. Circulation (1994) 3.30
Apoptosis in human atherosclerosis and restenosis. Circulation (1995) 3.30
Podocin, a raft-associated component of the glomerular slit diaphragm, interacts with CD2AP and nephrin. J Clin Invest (2001) 3.22
Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model. J Clin Invest (1994) 3.11
Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia. Circulation (1999) 2.92
Rescue of diabetes-related impairment of angiogenesis by intramuscular gene therapy with adeno-VEGF. Am J Pathol (1999) 2.83
Direct intramuscular gene transfer of naked DNA encoding vascular endothelial growth factor augments collateral development and tissue perfusion. Circulation (1996) 2.79
Stent thrombosis in the modern era: a pooled analysis of multicenter coronary stent clinical trials. Circulation (2001) 2.73
Reciprocal relation between VEGF and NO in the regulation of endothelial integrity. Nat Med (1997) 2.73
Birth of a biome: insights into the assembly and maintenance of the Australian arid zone biota. Mol Ecol (2008) 2.73
Radiation exposure to patients undergoing diagnostic and interventional cardiac catheterization procedures. Cathet Cardiovasc Diagn (1997) 2.67
Short-course raltegravir intensification does not reduce persistent low-level viremia in patients with HIV-1 suppression during receipt of combination antiretroviral therapy. Clin Infect Dis (2010) 2.51
Quality-of-life measurement in advanced cancer: assessing the individual. J Clin Oncol (1999) 2.48
Magnetic resonance mapping demonstrates benefits of VEGF-induced myocardial angiogenesis. Nat Med (1995) 2.29
Randomised trial of fish oil for prevention of restenosis after coronary angioplasty. Lancet (1989) 2.28
Vascular endothelial growth factor/vascular permeability factor enhances vascular permeability via nitric oxide and prostacyclin. Circulation (1998) 2.25
A conserved sequence in the immunoglobulin J kappa-C kappa intron: possible enhancer element. Nature (1983) 2.24
Clinical experience with the Palmaz-Schatz coronary stent. Initial results of a multicenter study. Circulation (1991) 2.23
Left ventricular remodeling after myocardial infarction: a corollary to infarct expansion. Circulation (1986) 2.22
Hypoxia induces vascular endothelial growth factor in cultured human endothelial cells. J Biol Chem (1995) 2.20
HMG-CoA reductase inhibitor mobilizes bone marrow--derived endothelial progenitor cells. J Clin Invest (2001) 2.20
Acute cardiac events temporally related to cocaine abuse. N Engl J Med (1986) 2.18
Favorable effect of VEGF gene transfer on ischemic peripheral neuropathy. Nat Med (2000) 2.13
Effect of reperfusion on biventricular function and survival after right ventricular infarction. N Engl J Med (1998) 2.12
Chemotactic properties of angiopoietin-1 and -2, ligands for the endothelial-specific receptor tyrosine kinase Tie2. J Biol Chem (1998) 2.12
Left ventricular electromechanical mapping to assess efficacy of phVEGF(165) gene transfer for therapeutic angiogenesis in chronic myocardial ischemia. Circulation (2000) 2.12
Indirect angiogenic cytokines upregulate VEGF and bFGF gene expression in vascular smooth muscle cells, whereas hypoxia upregulates VEGF expression only. Circulation (1994) 2.08
Local delivery of vascular endothelial growth factor accelerates reendothelialization and attenuates intimal hyperplasia in balloon-injured rat carotid artery. Circulation (1995) 2.07
Anti-angiogenic cues from vascular basement membrane collagen. Cancer Res (2000) 2.06
Transcatheter closure of ventricular septal defects. Circulation (1988) 2.05
Effect of intracoronary recombinant human vascular endothelial growth factor on myocardial perfusion: evidence for a dose-dependent effect. Circulation (2000) 2.05
Vascular endothelial growth factor(165) gene transfer augments circulating endothelial progenitor cells in human subjects. Circ Res (2000) 2.04
Extravasation of thrombus into the aortic root: a complication following use of an infusion catheter for intragraft thrombolysis. Cathet Cardiovasc Diagn (1996) 2.03
Our national obsession with potassium. Am J Med (1982) 2.02
Comparison of immediate invasive, delayed invasive, and conservative strategies after tissue-type plasminogen activator. Results of the Thrombolysis in Myocardial Infarction (TIMI) Phase II-A trial. Circulation (1990) 2.01
A prospective study of preferred versus actual place of death among patients referred to a palliative care home-care service. Ir Med J (2002) 2.00
Balloon dilatation of calcific aortic stenosis in elderly patients: postmortem, intraoperative, and percutaneous valvuloplasty studies. Circulation (1986) 2.00
Multicenter trial of the wallstent in the iliac and femoral arteries. J Vasc Interv Radiol (1997) 1.98
Human nonmuscle myosin heavy chains are encoded by two genes located on different chromosomes. Circ Res (1991) 1.98
Incidence and treatment of 'no-reflow' after percutaneous coronary intervention. Circulation (1994) 1.98
Coronary artery narrowing in coronary heart disease: comparison of cineangiographic and necropsy findings. Ann Intern Med (1979) 1.96
Transcatheter closure of coronary artery fistulas. J Am Coll Cardiol (1992) 1.93
Synergistic effect of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in vivo. Circulation (1995) 1.92
PR39, a peptide regulator of angiogenesis. Nat Med (2000) 1.90
Identification of 92-kD gelatinase in human coronary atherosclerotic lesions. Association of active enzyme synthesis with unstable angina. Circulation (1995) 1.90
A robust measure of HIV-1 population turnover within chronically infected individuals. Mol Biol Evol (2004) 1.87
Linkage of a nasopharyngeal carcinoma susceptibility locus to the HLA region. Nature (1990) 1.87
Remote frozen section service: a telepathology project in northern Norway. Hum Pathol (1991) 1.83
Expression of transforming growth factor-beta 1 is increased in human vascular restenosis lesions. J Clin Invest (1992) 1.82
Synectin, syndecan-4 cytoplasmic domain binding PDZ protein, inhibits cell migration. J Cell Physiol (2000) 1.82
Hypoxia-induced paracrine regulation of vascular endothelial growth factor receptor expression. J Clin Invest (1996) 1.82
Role of superficial femoral artery puncture in the development of pseudoaneurysm and arteriovenous fistula complicating percutaneous transfemoral cardiac catheterization. Cathet Cardiovasc Diagn (1992) 1.82
Real-life radiation burden to relatives of patients treated with iodine-131: a study in eight centres in Flanders (Belgium). Eur J Nucl Med (1998) 1.79
Long-range correlation properties of coding and noncoding DNA sequences: GenBank analysis. Phys Rev E Stat Phys Plasmas Fluids Relat Interdiscip Topics (1995) 1.78
Predictors of event-free survival after balloon aortic valvuloplasty. N Engl J Med (1991) 1.78
Estrogen and angiogenesis: A review. Arterioscler Thromb Vasc Biol (2001) 1.76
VEGF, flk-1, and flt-1 expression in a rat myocardial infarction model of angiogenesis. Am J Physiol (1996) 1.75
Linguistic features of noncoding DNA sequences. Phys Rev Lett (1994) 1.75
Reversal of experimental diabetic neuropathy by VEGF gene transfer. J Clin Invest (2001) 1.73
Coronary atherectomy. Clinical, angiographic, and histological findings and observations regarding potential mechanisms. Circulation (1990) 1.73
Antisense oligonucleotide inhibition of PDGFR-beta receptor subunit expression directs suppression of intimal thickening. Circulation (1997) 1.72